To develop regenerative medicine therapeutic applications
based on the Feldan shuttle platform

Feldan has developed a protein based Shuttle Platform Technology
that enables the delivery of functional proteins inside cells to induce genetic modifications,
or to modulate gene expression or cell physiology.

Feldan is a biotechnology company helping researchers involved in Cell therapy and Regenerative Medicine by providing premium high quality clinical and GMP grade ancillary materials including cytokines, transcription factors, and other recombinant proteins critical to the development and applications of cell therapy.